Prostate Cancer
Recent studies by T.N. Eade and co-authors add new data to prostate cancer findings
Published in Cancer Weekly, July 1st, 2008
In this recent study, researchers in the United States conducted a study "To compare the toxicity and biochemical outcomes of intensity-modulated radiation therapy (IMRT) and I-125 tran perineal permanent prostate seed implant (1251) for patients with low-risk prostate cancer. Between 1998 and 2004, a total of 374 low-risk patients (prostate-specific antigen < 10 ng/ ml, T1c-T2b, Gleason score of 6 or less, and no neoadjuvant hormones) were treated at Fox Chase Cancer Center (216 IMRT and 158 I-125 patients)."
"Median follow-up was 43 months for IMRT and 48 months for I-125. The IMRT prescription dose ranged from 74-78 Gy, and I-125 prescription was 145 Gy. Acute...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-07-01)
More Articles from Cancer Weekly
- JAMA and Archives Journals
Radiation treatment for cancer after radical prostatectomy linked with increased survival - Addiction Medicine
"Magic Meadow Therapy - Guidance to Happiness" Now Available in English! - Cancer Gene Therapy
Data on cancer gene therapy described by researchers at Thomas Jefferson University - Cancer Gene Therapy
Data on cancer gene therapy discussed by P. Gao and colleagues - Cancer Gene Therapy
New cancer gene therapy data have been reported by researchers at University of Utrecht - Cancer Gene Therapy
New cancer gene therapy research has been reported by scientists at University of California - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
